Oxlumo Indication Expanded to Include Patients With Advanced PH1
The approval was based on data from the phase 3 ILLUMINATE-C study that included 21 dialysis-independent and -dependent patients with PH1.
The approval was based on data from the phase 3 ILLUMINATE-C study that included 21 dialysis-independent and -dependent patients with PH1.
Climate change can affect older patients with asthma, COPD, allergies, kidney disease, and other conditions.
The Company is currently evaluating OCE-205 in a phase 2 trial in adults who have developed hepatorenal syndrome with acute kidney injury.
MK-2060 is an investigational monoclonal antibody designed to inhibit the activation of Factor XI and its ability to activate downstream proteins.
NephroScan is a sterile, single-dose kit for the preparation of technetium Tc 99m succimer injection for intravenous use.
To help patients gain access to treatment, Calliditas Therapeutics has launched a patient support program called Tarpeyo Touchpoints.
The product is available through a network of specialty pharmacies and distributors.
The approval was based on data from a phase 3 study that evaluated the efficacy and safety of Tarpeyo in 299 adults with primary IgAN.
Cortrophin Gel is a purified adrenocorticotropic hormone.
Purified Cortrophin Gel is a purified adrenocorticotropic hormone.